Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer
- 31 March 2006
- journal article
- research article
- Published by Elsevier BV in European Journal of Surgical Oncology
- Vol. 32 (2), 148-152
- https://doi.org/10.1016/j.ejso.2005.11.008
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Treatment-Related Upper Limb Morbidity 1 Year after Sentinel Lymph Node Biopsy or Axillary Lymph Node Dissection for Stage I or II Breast CancerAnnals of Surgical Oncology, 2004
- The Risk of Axillary Relapse After Sentinel Lymph Node Biopsy for Breast Cancer Is Comparable With That of Axillary Lymph Node DissectionAnnals of Surgery, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Short‐term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinomaCancer, 2003
- Comparison of morbidity between axillary lymph node dissection and sentinel node biopsyEuropean Journal of Surgical Oncology, 2003
- The decline in cancer mortality in the European Union, 1988–1996European Journal of Cancer, 2000
- Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodesThe Lancet, 1997
- Volume measurement in lymphoedema treatment: examination of formulaeEuropean Journal of Cancer Care, 1995
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Comparison of pain, motion, and edema after modified radical mastectomy vs. local excision with axillary dissection and radiationBreast Cancer Research and Treatment, 1992